Importantly, in IBD patients during clinical and endoscopic remission, peripheral blood-derived Tregs express higher CD39 levels [73]; further, therapeutic drug levels in responders are associated with higher CD39 expression in FOXP3+ Tregs [73]. The gene discussed is ENTPD1; the disease is inflammatory bowel disease.